New study aims to improve repeat eyelid surgery for trichiasis in east africa
NCT ID NCT07322302
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests two surgical methods for repeat eyelid surgery in people with trichiasis, a condition where eyelashes rub against the eye. About 1,000 participants in Tanzania will receive either the B-RAP or BLTR procedure. The goal is to see which technique better prevents eyelashes from growing back inward and improves eyelid shape and quality of life over two years.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- surgical procedure (B-RAP or BLTR)
- What this could lead to
- If successful, this could establish a better surgical method for repeat trichiasis, reducing recurrence and improving vision-related quality of life for many people.
- What could go wrong
- This is a surgical technique comparison, not a new drug or cure. Results may vary by surgeon skill, and long-term benefits beyond two years are not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 1,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Aug 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * One or both eyes with upper eyelid PTT, with a plan to undergo PTT surgery * Previous upper eyelid TT surgery in the study eye(s) * Collection of all baseline data prior to randomization * Signed, informed consent Exclusion Criteria: * Unable to provide informed consent * All eyes with previously operated trichiasis that are phthisical
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Eye diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites in 2 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Kongwa Trachoma Project
RECRUITINGMtwara, Tanzania
-
University of North Carolina
RECRUITINGChapel Hill, North Carolina, 27599, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill tame thyroid eye disease?
- 5,000 seniors join landmark eye health study to unlock secrets of aging vision
- New eye scan may spot glaucoma before vision loss begins
- New eye drops aim to replace reading glasses – but are they safe Long-Term?
- Laser before eye implant may prevent glaucoma damage
- Eye camera spots hidden inflammation in MS patients